Hypoxia-activated prodrug enhances therapeutic effect of sunitinib in melanoma.
Liu S, Tetzlaff MT, Wang T, Chen X, Yang R, Kumar SM, Vultur A, Li P, Martin JS, Herlyn M, Amaravadi R, Li B, Xu X.
Liu S, et al. Among authors: wang t.
Oncotarget. 2017 Dec 5;8(70):115140-115152. doi: 10.18632/oncotarget.22944. eCollection 2017 Dec 29.
Oncotarget. 2017.
PMID: 29383148
Free PMC article.